4/10
08:05 am
pcvx
Vaxcyte, Inc. (NASDAQ: PCVX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $95.00 price target on the stock.
Medium
Report
Vaxcyte, Inc. (NASDAQ: PCVX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $95.00 price target on the stock.
4/7
08:01 am
pcvx
Phathom Pharma, Rhythm, Vaxcyte most likely takeover targets in pharma - analyst [Seeking Alpha]
Low
Report
Phathom Pharma, Rhythm, Vaxcyte most likely takeover targets in pharma - analyst [Seeking Alpha]
4/2
04:05 pm
pcvx
Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference
Low
Report
Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference
3/27
10:16 am
pcvx
Ford Hutman Media Announces the Promotion of Julia Fuller to Managing Partner [Yahoo! Finance]
Neutral
Report
Ford Hutman Media Announces the Promotion of Julia Fuller to Managing Partner [Yahoo! Finance]
3/26
02:10 am
pcvx
Sutro Biopharma GAAP EPS of -$1.78 beats by $1.31, revenue of $153.73M beats by $101.4M [Seeking Alpha]
Low
Report
Sutro Biopharma GAAP EPS of -$1.78 beats by $1.31, revenue of $153.73M beats by $101.4M [Seeking Alpha]
3/25
04:43 pm
pcvx
Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated Milestones [Yahoo! Finance]
Low
Report
Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated Milestones [Yahoo! Finance]
3/4
08:42 am
pcvx
Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants [Yahoo! Finance]
Low
Report
Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants [Yahoo! Finance]
3/4
08:30 am
pcvx
Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants
Low
Report
Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants
11/6/2023
04:03 pm
pcvx
vaxcyte, inc.
MISS
Report
4.1%
vaxcyte, inc.
5/8/2023
04:03 pm
pcvx
vaxcyte, inc.
BEAT
Report
4.8%
vaxcyte, inc.
4/22
04:42 pm
pcvx
Form 4 Vaxcyte, Inc. For: Apr 18 Filed by: GUGGENHIME ANDREW
Low
Report
Form 4 Vaxcyte, Inc. For: Apr 18 Filed by: GUGGENHIME ANDREW
4/19
04:32 pm
pcvx
Form 4 Vaxcyte, Inc. For: Apr 17 Filed by: Wassil Jim
Low
Report
Form 4 Vaxcyte, Inc. For: Apr 17 Filed by: Wassil Jim
4/18
04:02 pm
pcvx
Form 144 Vaxcyte, Inc. Filed by: GUGGENHIME ANDREW
Low
Report
Form 144 Vaxcyte, Inc. Filed by: GUGGENHIME ANDREW
4/15
04:31 pm
pcvx
Form ARS Vaxcyte, Inc. For: Dec 31
Low
Report
Form ARS Vaxcyte, Inc. For: Dec 31
4/15
04:08 pm
pcvx
Form DEFA14A Vaxcyte, Inc.
Low
Report
Form DEFA14A Vaxcyte, Inc.
4/15
04:06 pm
pcvx
Form DEF 14A Vaxcyte, Inc. For: Jun 06
Low
Report
Form DEF 14A Vaxcyte, Inc. For: Jun 06
4/3
04:23 pm
pcvx
Form 4 Vaxcyte, Inc. For: Apr 01 Filed by: Eydelman Mikhail
Low
Report
Form 4 Vaxcyte, Inc. For: Apr 01 Filed by: Eydelman Mikhail
4/3
04:22 pm
pcvx
Form 4 Vaxcyte, Inc. For: Apr 01 Filed by: Wassil Jim
Low
Report
Form 4 Vaxcyte, Inc. For: Apr 01 Filed by: Wassil Jim
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register